Please login to the form below

Not currently logged in
Email:
Password:

AbbVie appoints new GMs for France and the UK

Jérôme Bouyer and Pierre-Claude Fumoleau take up new roles at the pharma firm

Jerome BouyerAbbVie has appointed Jérôme Bouyer (pictured right) as its UK general manager and Pierre-Claude Fumoleau as its general manager for the French division.

Bouyer joined AbbVie in 2012 as its general manager for Belgium and was subsequently promoted to his most recent position as general manager, France.

Prior to joining AbbVie, Bouyer worked at Novartis where he held several positions including head of business operations and strategic planning for Europe in Basel, head of marketing and specialty products in Belgium, specialty business head in France and chief marketing officer for China.Pierre-Claude Fumoleau

Taking over from Bouyer as general manager, France is Pierre-Claude Fumoleau (pictured left), re-joined Abbott in 2011 before being promoted to director of immunology at AbbVie, the research-based pharma business that was subsequently spun-off from Abbott.

Fumoleau has also served the likes of Bristol-Myers Squibb in various positions in marketing and sales and as Astra-Zeneca’s director of oncology.

12th June 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
wethepeople

wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics